Lactobacillus rhamnosus R11 consumed in a food supplement survived human digestive transit without modifying microbiota equilibrium as assessed by real-time polymerase chain reaction

Journal of Molecular Microbiology and Biotechnology

Volumn 14, Issue 1-3, 2007, Pages 90-99

  Firmesse, Olivier ^a   Mogenet, Agnès ^b   Bresson, Jean Louis ^b   Corthier, Gérard ^a   Furet, Jean Pierre ^a  

^a CEMAGREF   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Human gastrointestinal tract microbiota; Lactobacillus rhamnosus; Polymerase chain reaction, real time; Probiotic; Survival

Indexed keywords

PROBIOTIC AGENT;

ADULT; ARTICLE; BACTERIAL STRAIN; BACTERIAL SURVIVAL; COLONY FORMING UNIT; CONTROLLED STUDY; DIET SUPPLEMENTATION; DILUTION; FECES ANALYSIS; FEMALE; FERMENTATION; GASTROINTESTINAL TRANSIT; HOMEOSTASIS; HUMAN; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS RHAMNOSUS; MALE; MICROBIOLOGY; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; BACTEROIDES; BIFIDOBACTERIUM; CLOSTRIDIUM; COLONY COUNT, MICROBIAL; FECES; FEMALE; GASTROINTESTINAL TRACT; HUMANS; LACTOBACILLUS RHAMNOSUS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROBIOTICS; RNA, RIBOSOMAL, 16S; TREATMENT OUTCOME;

BACTERIA (MICROORGANISMS); BACTEROIDES SP.; BIFIDOBACTERIUM SP.; CLOSTRIDIUM COCCOIDES; CLOSTRIDIUM LEPTUM; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS RHAMNOSUS;

EID: 35448987657     PISSN: 14641801     EISSN: None     Source Type: Journal    
DOI: 10.1159/000106087     Document Type: Article

References (44)

1. Alander M, Satokari R, Korpela R, Saxelin M, Vilpponen-Salmela T, Mattila-Sandholm T, von Wright A: Persistence of colonization of human colonic mucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption. Appl Environ Microbiol 1999;65:351-354.
2. Borriello SP, Hammes WP, Holzapfel W, Marteau P, Schrezenmeir J, Vaara M, Valtonen V: Safety of probiotics that contain lactobacilli or bifidobacteria. Clin Infect Dis 2003;36:775-780.
3. Chandramouli V, Kailasapathy K, Peiris P, Jones M: An improved method of microencapsulation and its evaluation to protect Lactobacillus spp. in simulated gastric conditions. J Microbiol Methods 2004;56:27-35.
4. Contrepois M, Gouet P: Utilisation d'une technique microbiologique pour la mesure de la vitesse des microparticules dans le tractus digestif des ruminants. C R Acad Sci (Paris) 1969;268:1757-1759.
5. de Champs C, Maroncle N, Balestrino D, Rich C, Forestier C: Persistence of colonization of intestinal mucosa by a probiotic strain, Lactobacillus casei subsp. rhamnosus Lcr35, after oral consumption. J Clin Microbiol 2003;41:1270-1273.
6. del Campo R, Bravo D, Canton R, Ruiz-Garbajosa P, Garcia-Albiach R, Montesi-Libois A, Yuste FJ, Abraira V, Baquero F: Scarce evidence of yogurt lactic acid bacteria in human faeces after daily yogurt consumption by healthy volunteers. Appl Environ Microbiol 2005;71:547-549.
7. Drouault S, Corthier G: Health effects of lactic acid bacteria ingested in fermented milk. Vet Res 2001;32:101-117.
8. Drouault S, Corthier G, Ehrlich SD, Renault P: Survival, physiology, and lysis of Lactococcus lactis in the digestive tract. Appl Environ Microbiol 1999;65:4881-4886.
9. Fuller R: Probiotics in human medicine. Gut 1991;32:439-442.
10. Furet JP, Quenee P, Tailliez P: Molecular quantification of lactic acid bacteria in fermented milk products using real-time quantitative PCR. Int J Food Microbiol 2004;97:197-207.
11. Gardiner G, Ross RP, Collins JK, Fitzgerald G, Stanton C: Development of a probiotic cheddar cheese containing human-derived Lactobacillus paracasei strains. Appl Environ Microbiol 1998;64:2192-2199.
12. Gibson GR, Beatty ER, Wang X, Cummings JH: Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 1995;108:975-982.
13. Harmsen HJ, Gibson GR, Elfferich P, Raangs GC, Wildeboer-Veloo AC, Argaiz A, Roberfroid MB, Welling GW: Comparison of viable cell counts and fluorescence in situ hybridization using specific rRNA-based probes for the quantification of human fecal bacteria. FEMS Microbiol Lett 2000;183:125-129.
14. Kalliomaki M, Isolauri E: Pandemic of atopic diseases - a lack of microbial exposure in early infancy? Curr Drug Targets Infect Disord 2002;2:193-199.
15. Kanauchi O, Mitsuyama K, Araki Y, Andoh A: Modification of intestinal flora in the treatment of inflammatory bowel disease. Curr Pharm Des 2003;9:333-346.
16. Lahtinen SJ, Gueimonde M, Ouwehand AC, Reinikainen JP, Salminen SJ: Probiotic bacteria may become dormant during storage. Appl Environ Microbiol 2005;71:1662-1663.
17. Lay C, Rigottier-Gois L, Holmstrom K, Rajilic M, Vaughan EE, de Vos WM, Collins MD, Thiel R, Namsolleck P, Blaut M, Dore J: Colonic microbiota signatures across five northern European countries. Appl Environ Microbiol 2005;71:4153-4155.
18. Lyons SR, Griffen AL, Leys EJ: Quantitative realtime PCR for Porphyromonas gingivalis and total bacteria. J Clin Microbiol 2000;6:2362-2365.
19. Marteau P, Seksik P, Jian R: Probiotics and intestinal health effects: a clinical perspective. Br J Nutr 2002;88(suppl 1):S51-S57.
20. Matsuki T, Watanabe K, Fujimoto J, Takada T, Tanaka R: Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human faeces. Appl Environ Microbiol 2004;70:7220-7228.
21. Matte-Tailliez O, Quénée P, Van Opstal J, Dessevre F, Firmesse O, Tailliez P: Detection and identification of lactic acid bacteria in milk and industrial starter culture with fluorescently labeled rRNA targeted peptide nucleic acid probes. Lait 2001;81:237-248.
22. Mercenier A, Pavan S, Pot B: Probiotics as biotherapeutic agents: present knowledge and future prospects. Curr Pharm Des 2003;9:175-191.
23. Oozeer R, Goupil-Feuillerat N, Alpert CA, van de Guchte M, Anba J, Mengaud J, Corthier G: Lactobacillus casei is able to survive and initiate protein synthesis during its transit in the digestive tract of human flora-associated mice. Appl Environ Microbiol 2002;68:3570-3574.
24. Oozeer R, Mater DD, Goupil-Feuillerat N, Corthier G: Initiation of protein synthesis by a labeled derivative of the Lactobacillus casei DN-114 001 strain during transit from the stomach to the cecum in mice harboring human microbiota. Appl Environ Microbiol 2004;70:6992-6997.
25. Ott SJ, Musfeldt M, Ullmann U, Hampe J, Schreiber S: Quantification of intestinal bacterial populations by real-time PCR with a universal primer set and minor groove binder probes: a global approach to the enteric flora. J Clin Microbiol 2004;42:2566-2572.
26. Ouwehand AC, Salminen S, Isolauri E: Probiotics: an overview of beneficial effects. Antonie Van Leeuwenhoek 2002;82:279-289.
27. Ouwehand AC, Salminen SJ: The health effects of cultured milk products with viable and non-viable bacteria. Int Dairy J 1998;8:749-758.
28. Phillips M, Kailasapathy K, Tran L: Viability of commercial probiotic cultures (L. acidophilus, Bifidobacterium sp., L. casei , L. paracasei and L. rhamnosus) in cheddar cheese. Int J Food Microbiol 2006;108:276-280.
29. Rachmilewitz D, Katakura K, Karmeli F, Hayashi T, Reinus C, Rudensky B, Akira S, Takeda K, Lee J, Takabayashi K, Raz E: Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 2004;126:520-528.
30. Rinttila T, Kassinen A, Malinen E, Krogius L, Palva A: Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J Appl Microbiol 2004;97:1166-1177.
31. Salminen S, Bouley C, Boutron-Ruault MC, Cummings JH, Franck A, Gibson GR, Isolauri E, Moreau MC, Roberfroid M, Rowland I: Functional food science and gastrointestinal physiology and function. Br J Nutr 1998;80(suppl 1):S147-S171.
32. Saxelin M, Pessi T, Salminen S: Fecal recovery following oral administration of Lactobacillus strain GG (ATCC 53103) in gelatine capsules to healthy volunteers. Int J Food Microbiol 1995;25:199-203.
33. Seksik P, Rigottier-Gois L, Gramet G, Sutren M, Pochart P, Marteau P, Jian R, Dore J: Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 2003;52:237-242.
34. Sghir A, Gramet G, Suau A, Rochet V, Pochart P, Dore J: Quantification of bacterial groups within human fecal flora by oligonucleotide probe hybridization. Appl Environ Microbiol 2000;66:2263-2266.
35. Shah NP: Probiotic bacteria: selective enumeration and survival in dairy foods. J Dairy Sci 2000;83:894-907.
36. Suau A, Bonnet R, Sutren M, Godon JJ, Gibson GR, Collins MD, Dore J: Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol 1999;65:4799-4807.
37. Sullivan A, Nord CE: The place of probiotics in human intestinal infections. Int J Antimicrob Agents 2002;20:313-319.
38. Sultana K, Godward G, Reynolds N, Arumugaswamy R, Peiris P, Kailasapathy K: Encapsulation of probiotic bacteria with alginatestarch and evaluation of survival in simulated gastrointestinal conditions and in yoghurt. Int J Food Microbiol 2000;62:47-55.
39. Suzuki MT, Taylor LT, Delong EF: Quantitative analysis of small-subunit rRNA genes in mixed microbial populations via 5′-nuclease assays. Appl Environ Microbiol 2000;66:4605-4614
40. Tannock GW, Munro K, Harmsen HJ, Welling GW, Smart J, Gopal PK: Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20. Appl Environ Microbiol 2000;66:2578-2588.
41. Thompson JD, Higgins DG, Gibson TJ: Improved sensitivity of profile searches through the use of sequence weights and gap excision. Comput Appl Biosci 1994;10:19-29.
42. Vesa T, Pochart P, Marteau P: Pharmacokinetics of Lactobacillus plantarum NCIMB 8826, Lactobacillus fermentum KLD, and Lactococcus lactis MG 1363 in the human gastrointestinal tract. Aliment Pharmacol Ther 2000;14:823-828.
43. Walter J, Tannock GW, Tilsala-Timisjarvi A, Rodtong S, Loach DM, Munro K, Alatossava T: Detection and identification of gastrointestinal Lactobacillus species by using denaturing gradient gel electrophoresis and species-specific PCR primers. Appl Environ Microbiol 2000;66:297-303.
44. Zoetendal EG, Akkermans AD, De Vos WM: Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl Environ Microbiol 1998;64:3854-3859.